Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by dysregulated growth and the proliferation of myeloid cells in the bone marrow caused by the …
Materials and methods Retrospective data from the records of the National Center for Cancer Care and Research from December 20, 2021, to January 30, 2022. Participants …
D Abushanab, S Chbib, R Kaddoura… - Journal of Medical …, 2024 - Taylor & Francis
Aim To evaluate the cost-effectiveness of dapagliflozin added to standard of care (SoC) versus SoC in heart failure with reduced ejection fraction (HFrEF) and without type 2 …
AF Al-Mashdali, HN Al-Dubai… - Acta Bio Medica: Atenei …, 2022 - ncbi.nlm.nih.gov
Objective: Avascular necrosis (AVN) has been encountered in hematological malignancies; nonetheless, AVN is extremely uncommon in patients with chronic myeloid leukemia (CML) …
S Sasi, M Mohamed, P Chitrambika… - Acta Bio Medica: Atenei …, 2021 - ncbi.nlm.nih.gov
Myasthenia Gravis (MG) is a rare neurological condition characterized by muscle weakness that worsens after use. Myeloproliferative Neoplasms (MPNs) are disorders due to stem-cell …
AHW Hajjar, S Abbarh, A Al-Mashdali, A Alshurafa… - Cureus, 2022 - ncbi.nlm.nih.gov
Tumor lysis syndrome (TLS) is a hematological emergency. This syndrome is characterized by metabolic derangements such as hyperkalemia and hypocalcemia, which result from …
Z Maat, K Mushtaq, MA Yassin - Case Reports in Oncology, 2022 - karger.com
Dasatinib is a BCR-ABL tyrosine kinase inhibitor which was approved in 2006 for the treatment of adults diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid …
OM Ismail, A Amer, FA Ibrahim, M Abu-Tineh… - Case Reports in …, 2022 - karger.com
The coexistence of dual hematological neoplasms is an unusual and challenging presentation due to the different combination of etiopathology. The presentation of …
Abstract Background: Philadelphia negative Myeloproliferative neoplasms classically characterized by excess production of terminal myeloid cells in the peripheral blood. Among …